Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TrkB signaling: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Activity-Dependent Synaptic Tagging via CREB-BDNF-TrkB Signa | 0.623 | synaptic biology | What determines the selectivity of compl |
| 5-HT2A/C Silencing Enables Sustained BDNF-TrkB Signaling for | 0.545 | - | What is the minimum effective dose of tr |
| HBOT at 2.0 ATA for 60 min, 5x/week for 6 weeks enhances hip | 0.450 | neurodegeneration | What are the optimal oxygen pressure, du |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.589
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning TrkB signaling in their description or question text
No additional research found